MedTrace Logo

Biomarkers in Post-Menopausal Women Receiving Flaxseed

NCT01698294 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 258

Last updated 2022-05-09

No results posted yet for this study

Summary

This randomized clinical trial studies biomarkers in post-menopausal women receiving flaxseed. Studying samples of blood, urine, and feces in the laboratory from participants receiving flaxseed may help doctors understand the effects of flaxseed on biomarkers.

Conditions

  • No Evidence of Disease

Interventions

OTHER

Clinical Observation

Participants maintain usual diet and undergo clinical observation

DIETARY_SUPPLEMENT

Flaxseed

Given PO

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • Fred Hutchinson Cancer Center

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • State University of New York at Buffalo

    collaborator OTHER

  • University of Toronto

    collaborator OTHER

  • Roswell Park Cancer Institute

    lead OTHER

Principal Investigators

  • Spencer Rosario, PhD · Roswell Park Cancer Institute

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-14
Primary Completion
2017-06-08
Completion
2017-06-08

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01698294 on ClinicalTrials.gov